Results 1 to 10 of about 13,950 (151)

Impact of Fungal Co-Infection on Teicoplanin Plasma Trough Concentration in Critically Ill Adults: A Novel Consideration for Dose Adjustment [PDF]

open access: yesDrug Design, Development and Therapy
Lin Cheng,1,* Lina Wang,2,* Xi You,1 Lirong Xiong,1 Qing Dai,1 Qian Wang1 1Department of Pharmacy, The First Affiliated Hospital of Army Medical University, Chongqing, People’s Republic of China; 2Department of Obstetrics and Gynecology ...
Cheng L   +5 more
doaj   +2 more sources

Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2020
Background/Aims Teicoplanin can be used as an alternative to vancomycin when treating beta-lactam-resistant gram-positive bacterial infections. Both vancomycin and teicoplanin are associated with relatively high rates of adverse drug reactions (ADRs ...
Byung-Keun Kim   +5 more
doaj   +1 more source

Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?

open access: yesPharmaceuticals, 2021
Teicoplanin is an antibiotic that has been actively used in medical practice since 1986 to treat serious Gram-positive bacterial infections. Due to its efficiency and low cytotoxicity, teicoplanin has also been used for patients with complications ...
Vladimir Vimberg
doaj   +1 more source

Teicoplanin-Resistant Coagulase-Negative Staphylococci: Do the Current Susceptibility Testing Methods Reliably Detect This Elusive Phenotype?

open access: yesAntibiotics, 2023
Coagulase-negative staphylococci (CoNS), members of the skin commensal microbiota, are increasingly associated with local or systemic infections due to a shift in patient populations in recent decades.
Adriana D. Balasiu, Colin R. MacKenzie
doaj   +1 more source

Comparison of Different Phenotypic Methods Including E-test, Cefoxitin and Oxacillin Disk Diffusion for Detection of Methicillin Resistant Staphylococcus aureus [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Methicillin-Resistant Staphylococcus aureus (MRSA) has spread throughout the world as a hospital and communityacquired illness. Although, a variety of strategies have been employed, laboratory identification of MRSA remains a difficulty.
Geeta Gupta, Pradeep Kumar
doaj   +1 more source

Increased incidence of teicoplanin-non-susceptible Staphylococcus epidermidis strains: a 6-year retrospective study

open access: yesScientific Reports, 2023
Glycopeptide antibiotics (vancomycin and teicoplanin) are usually used for the treatment of Staphylococcus epidermidis infections owing to their increased oxacillin resistance. However, S.
Subin Kim   +4 more
doaj   +1 more source

Prospective study of irrational prescription of teicoplanin in a large academic hospital: A dilemma of antimicrobial resistance

open access: yesJournal of Research in Pharmacy Practice, 2020
Objective: Teicoplanin is an antibiotic used to treat severe Gram-positive infections, especially those caused by methicillin-resistant Staphylococcus aureus(MRSA).
Masoud Hajialigol   +2 more
doaj   +1 more source

Efficacy of teicoplanin in bloodstream infections caused by Enterococcus faecium: posthoc analysis of a nationwide surveillance

open access: yesInternational Journal of Infectious Diseases, 2022
Objectives: Vancomycin and teicoplanin are glycopeptides with activity against Enterococcus faecium. However, studies on the clinical efficacy of teicoplanin are limited.
Soyoung Ha   +9 more
doaj   +1 more source

Therapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation

open access: yesJournal of the Formosan Medical Association, 2020
Background: The optimal loading dose of teicoplanin in patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO) has never been determined by therapeutic drug monitoring. This study investigated the appropriateness of proposed loading
Guan-Jhou Chen   +5 more
doaj   +1 more source

Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication

open access: yesPharmaceuticals, 2021
The protracted global COVID-19 pandemic urges the development of new drugs against the causative agent SARS-CoV-2. The clinically used glycopeptide antibiotic, teicoplanin, emerged as a potential antiviral, and its efficacy was improved with lipophilic ...
Ilona Bereczki   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy